Skip to main content
CODX $0.26 -4.12%
CODX logo
CODX · Co-Diagnostics, Inc.
Track CODX — free
$0.26 -0.01 (-4.12%) At close · Nov 13 Play latest call Q2 2026 earnings call transcript
Market Cap
$2.72M
Shares
10.51M
Volume · Nov 13 591.94K Avg daily vol (3M) 1.97M
All webcasts

Earnings call · FY2026 Q3

Co-Diagnostics, Inc. (CODX) Q3 2026 Earnings Call

Concluded Nov 10, 2026
Nov 10, 2026
Period
FY2026 Q3
Runtime
—
Sources
2 artifacts
Revenue $282,881 +94.6% YoY
Diluted EPS -$1.01
Gross margin -7.2% -89.1 pp YoY
Net income -$6.31M
Open full screen 8-K 10-Q

Executive readout · one minute

What the filings say

8-K earnings release · filed Nov 10, 2026
Co-Diagnostics reported third-quarter revenue of $0.3 million versus $0.1 million in the third quarter of 2025, but net loss was $6.3 million versus $5.9 million. Cash and cash equivalents totaled $0.7 million as of September 30, 2026.
10-Q report · filed Nov 10, 2026
Co-Diagnostics reported $0.7 million cash and cash equivalents at September 30, 2026, versus total current liabilities of $2.5 million, and said additional capital is required, creating substantial doubt about its ability to continue as a going concern.

The audio replay and transcript follow the call.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · regions

United States$270,987 +98.2% YoY
Non Us$11,894 +37.7% YoY
Full-screen source Call document